|
Market Closed -
NSE India S.E.
07:05:08 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 395.15 INR | +1.65% |
|
-2.28% | +348.27% |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceutical Business | 10.52B | 12.16B | 12.97B | 5.62B | 6.49B | |||||
Total Assets | 18.01B | 18.24B | 11.65B | 14.38B | 16.73B | |||||
Interest Expense | -915M | -864M | -467M | -13.83M | -1.94M | |||||
Income Tax Expense | 147M | 387M | 1.6B | 72.7M | 77.3M | |||||
CAPEX | -184M | -128M | -445M | -644M | -877M | |||||
EBT | 125M | 865M | 5.82B | 2.58B | 508M | |||||
D&A | 1.3B | 574M | 533M | 221M | 282M | |||||
Net Income | -21.49M | 476M | 4.21B | 2.5B | 431M |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Export | 7.96B | 9.37B | 10.02B | 4.06B | 4.94B | |||||
Total Assets | 2.07B | 2.25B | 512M | - | - | |||||
Operating Income | 2.89B | 3.76B | 4.5B | - | - | |||||
India | 2.43B | 2.7B | 2.79B | 1.56B | 1.32B | |||||
Total Assets | 2.75B | 3.04B | 1.07B | - | - | |||||
Operating Income | 856M | 813M | 1.05B | - | - | |||||
Unallocated | - | - | - | - | - | |||||
Total Assets | 13.18B | 12.96B | 10.07B | - | - |
- Stock Market
- Stocks
- INDSWFTLAB Stock
- Financials Ind-Swift Laboratories Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
